Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2007
11/14/2007CN100348196C Benzotriazepines as gastrin and cholecystokinin receptor ligands
11/14/2007CN100348188C Dripping pills of andrographolide and its preparing method
11/14/2007CN100348178C 'Ganjing' dripping pills for treating liver disease and its preparation
11/14/2007CN100348175C Bistort drop pill and preparation method
11/14/2007CN100348174C Oral drop pill in use for clearing away heat and toxic material, relieving inflammation and alleviating pain, and preparation method
11/14/2007CN100348170C Yitongshu drop pill for treating pain and its preparation method
11/14/2007CN100348116C Lily tea with health-preserving function
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294648 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294621 Lipid analogs for combating tumors
11/13/2007US7294620 Lipid analogs for inhibiting HIV-1 activity
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007US7294337 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies
11/13/2007CA2473202C Pharmaceutical composition for regeneration of cirrhotic liver
11/13/2007CA2442483C 3-heterocyclylpropanohydroxamic acid pcp inhibitors
11/13/2007CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof
11/13/2007CA2396159C Novel substituted benzimidazole dosage forms and method of using same
11/13/2007CA2301132C Rapidly disintegrating methylcellulose tablets
11/13/2007CA2251008C Macromolecular complexes for drug delivery
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2209904C Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
11/08/2007WO2007126041A1 Benzisoxazole compound
11/08/2007WO2007126017A1 Agent for suppressing arteriosclerosis
11/08/2007WO2007125717A1 Agent for amelioration of dysphagia, and pharmaceutical or food composition comprising the same
11/08/2007WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet
11/08/2007WO2007124949A1 Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives
11/08/2007WO2007124734A2 Compounds a-r-x for the manufacture of pharmaceutical preparations
11/08/2007WO2007124617A1 Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses
11/08/2007WO2007124588A2 Colicinogenic strains of e. coli and use thereof for treatment of k88+-associated diarrhea
11/08/2007WO2005115075A3 Salt of 4- or 5- aminosalicylic acid
11/08/2007US20070259963 N-[5-methanesulfonyl-4-(4-methanesulfonyl-3-pentafluorosulfanylphenoxy)-2-methyl-benzoyl]guanidine; diagnostic agents for hypertension, diabetes, proliferative disorders; inhibitors of the cellular sodium-proton antiporter (Na/H exchanger); good absorption, bioavailability; angina pectoris, infarction
11/08/2007US20070259958 Prevention of Neutrophil Recruitment
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259906 Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259877 Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders
11/08/2007US20070259874 Phosphodiesterase Inhibitors
11/08/2007US20070259857 Amorphous form of Olanzapine
11/08/2007US20070259049 Process for preparing lansoprazole
11/08/2007US20070259037 Method and composition for treatment of inflammatory conditions
11/08/2007US20070258982 Methods of using antibodies against human IL-22
11/08/2007US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007US20070258955 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/08/2007DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007CA2650716A1 Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives
11/08/2007CA2650577A1 Use of 12-imidazolyl-1-dodecanol or its pharmaceutically acceptable salts for producing a pharmaceutical preparation
11/08/2007CA2649992A1 A colicinogenic strain of e. coli
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852433A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/07/2007EP1852423A1 Crystal of 4(3h)-quinazolinone derivative
11/07/2007EP1852129A1 Remedy for irritable bowel syndrome
11/07/2007EP1852122A1 Dental and gingival health compositions containing reactivatable, dehydrated, eubiotic micro-organisms
11/07/2007EP1852121A2 Lipid analogs for treating viral infections
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1576961B1 Use of silymarin and carbopol as a regenerator of pancreatic tissue and cells with endocrine secretion damaged by diabetes mellitus
11/07/2007EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
11/07/2007EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
11/07/2007EP1401408A4 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1317276B1 Therapeutic use of a recombinant erythropoietin omega having high activity and reduced side effects
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base
11/07/2007EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
11/07/2007EP0939648B1 Rotavirus vaccine formulations
11/07/2007CN101068798A Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
11/07/2007CN101068786A 3-substituted pyridine derivatives as h3 antagonists
11/07/2007CN101068565A Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
11/07/2007CN101068560A Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent
11/07/2007CN101068547A Dose forms comprising VX-950 and their dosage regimen
11/07/2007CN101068541A Method of using punicic acid to enhance immune response and prevent metabolic disorders
11/07/2007CN101067213A New method for screening HCV-NS5B protein inhibitor from Chinese herb medicines natural products mixture alternate library
11/07/2007CN101067120A Fecal enterococcus CMS-II001 and its application
11/07/2007CN101067119A Fermenting lactobacillus CMS II002 and its application
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066981A Non-cyclic nucleoside phosphonate compound and its composition, prepn process and use
11/07/2007CN101066980A Crystalline tenofovir fumarate and its medicine prepn
11/07/2007CN101066970A Method for preparing medicine composition containing 1,3 oxathiolane nucleoside analogue
11/07/2007CN101066446A Chinese medicine composition for treating enteritis
11/07/2007CN101066445A Chinese medicine prepn for curing gastropathy radically
11/07/2007CN101066436A Medicine composition for treating gastric ulcer
11/07/2007CN101066435A Iprazole containing medicine
11/07/2007CN101066434A Omeprazole-containing medicine
11/07/2007CN101066421A Plaster for treating cholecystitis, cholangitis and bile gastritis
11/07/2007CN101066420A Hepatitis treating Chinese medicine prepn and its preparation process
11/07/2007CN101066418A Medicine containing colloidal bismuth for treating gastric uncer
11/07/2007CN101066416A Medicine containing rabeprazole for treating gastric ulcer
11/07/2007CN101066399A Chinese medicine prepn for treating recurrent aphtha
11/07/2007CN101066395A Health fig oral liquid
11/07/2007CN101066389A Medicine composition for preventing and treating peptic ulcer
11/07/2007CN101066376A Compound Chinese medicine prepn for treating stomatocace and its production process
11/07/2007CN101066358A Sanitary health Chinese medicine cushion
11/07/2007CN101066355A Chinese medicine prepn for treating toothache and its prepn process
11/07/2007CN101066349A Chinese herbal medicine composition for treating dizziness
11/07/2007CN101066342A Chinese medicine composition for treating hepatitis B
1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 1258